MPH Health Care Past Earnings Performance

Past criteria checks 3/6

MPH Health Care has been growing earnings at an average annual rate of 22.1%, while the Pharmaceuticals industry saw earnings growing at 8.4% annually. Revenues have been declining at an average rate of 1.7% per year. MPH Health Care's return on equity is 11.8%, and it has net margins of 85.8%.

Key information

22.1%

Earnings growth rate

22.1%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate-1.7%
Return on equity11.8%
Net Margin85.8%
Next Earnings Update05 Sep 2024

Recent past performance updates

Shaky Earnings May Not Tell The Whole Story For MPH Health Care (FRA:93M1)

Sep 15
Shaky Earnings May Not Tell The Whole Story For MPH Health Care (FRA:93M1)

Recent updates

MPH Health Care AG (FRA:93M1) Held Back By Insufficient Growth Even After Shares Climb 30%

Jun 13
MPH Health Care AG (FRA:93M1) Held Back By Insufficient Growth Even After Shares Climb 30%

Shaky Earnings May Not Tell The Whole Story For MPH Health Care (FRA:93M1)

Sep 15
Shaky Earnings May Not Tell The Whole Story For MPH Health Care (FRA:93M1)

A Look At The Fair Value Of MPH Health Care AG (FRA:93M1)

Sep 02
A Look At The Fair Value Of MPH Health Care AG (FRA:93M1)

We're Interested To See How MPH Health Care (FRA:93M1) Uses Its Cash Hoard To Grow

Oct 02
We're Interested To See How MPH Health Care (FRA:93M1) Uses Its Cash Hoard To Grow

We're Not Worried About MPH Health Care's (FRA:93M1) Cash Burn

Jun 19
We're Not Worried About MPH Health Care's (FRA:93M1) Cash Burn

Revenue & Expenses Breakdown

How MPH Health Care makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:93M1 Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23343010
30 Sep 23334010
30 Jun 23315010
31 Mar 23313910
31 Dec 22312910
30 Sep 2210-2010
30 Jun 22-11-6810
31 Mar 221-3910
31 Dec 2114-910
30 Sep 2118-1210
30 Jun 2122-1410
31 Mar 2113-4210
31 Dec 203-7010
30 Sep 2020-3710
30 Jun 2038-310
31 Mar 2039410
31 Dec 19411110
30 Sep 1919-1310
30 Jun 19-3-3710
31 Mar 1921010
31 Dec 18453710
30 Sep 18646310
30 Jun 18849010
31 Mar 18596110
31 Dec 17343210
30 Sep 17224510
30 Jun 17105800
31 Mar 17106910
31 Dec 1698010
30 Sep 16839030
30 Jun 1615610050
31 Mar 162109170
31 Dec 152638380
30 Sep 152394390
30 Jun 152143100
31 Mar 15217480
31 Dec 14219560
30 Sep 14226660
30 Jun 14232700
31 Mar 14229700
31 Dec 13227660
30 Sep 13223930

Quality Earnings: 93M1 has high quality earnings.

Growing Profit Margin: 93M1's current net profit margins (85.8%) are lower than last year (95.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 93M1's earnings have grown significantly by 22.1% per year over the past 5 years.

Accelerating Growth: 93M1's earnings growth over the past year (1.5%) is below its 5-year average (22.1% per year).

Earnings vs Industry: 93M1 earnings growth over the past year (1.5%) exceeded the Pharmaceuticals industry 1.5%.


Return on Equity

High ROE: 93M1's Return on Equity (11.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.